Baycox Iron


toltrazuril / iron(iii) ion

This medicine is authorised for use in the European Union.


Baycox Iron is a veterinary medicine. It is used in young piglets on farms which have been affected in the past by the parasitic infection coccidiosis to prevent diarrhoea caused by a new coccidiosis infection. Coccidiosis is a disease of the gut which results in reduced growth due to diarrhoea.  Infected piglets shed disease spores (oocysts) in their faeces that can spread the infection. Baycox Iron is also used to reduce spread of the infection through passage of oocysts in faeces, and at the same time to prevent iron deficiency anaemia due to the limited iron reserves of new-born piglets, low iron content of milk and high growth rate of suckling piglets.

Baycox Iron contains the active substances toltrazuril and gleptoferron (an iron-containing compound).

This EPAR was last updated on 12/06/2019

Authorisation details

Product details
Baycox Iron
Agency product number
Active substance
Iron(iii) ion / toltrazuril
International non-proprietary name (INN) or common name
toltrazuril / iron(iii) ion
Pigs (piglets)
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Bayer Animal Health GmbH
Date of issue of marketing authorisation valid throughout the European Union
Contact address

D-51368 Leverkusen 

Product information

Baycox Iron - EMEA/V/C/004794 -


Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

toltrazuril, combinations

Therapeutic indication

For the concurrent prevention of clinical signs of coccidiosis (such as diarrhoea) in neonatal piglets on farms with a confirmed history of coccidiosis caused by Cystoisospora suis, and prevention of iron deficiency anaemia.

Assessment history

How useful was this page?

Add your rating